
Effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on podocytes, inflammation, and oxidative stress in patients with diabetic nephropathy (DN)
Author(s) -
Jie Liu,
Shan Guo,
Hui Li,
Xu-ying Liu
Publication year - 2022
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.38.5.4719
Subject(s) - medicine , endocrinology , diabetic nephropathy , nephrin , oxidative stress , malondialdehyde , liraglutide , diabetes mellitus , type 2 diabetes , proteinuria , podocyte , kidney
To investigate the effects of a glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide on podocytes, inflammation, and oxidative stress in patients with diabetic nephropathy (DN).